Continuum Advisory’s JPMorgan International Research Enhanced Equity ETF JIRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-135
Closed -$8.6K 1032
2025
Q1
$8.6K Buy
+135
New +$8.46K ﹤0.01% 1015
2024
Q4
Sell
-224
Closed -$13.7K 1915
2024
Q3
$13.7K Buy
+224
New +$14.4K ﹤0.01% 921
2023
Q3
Sell
-4,622
Closed -$264K 466
2023
Q2
$264K Sell
4,622
-905
-16% -$51K 0.04% 386
2023
Q1
$304K Sell
5,527
-118
-2% -$6.34K 0.05% 350
2022
Q4
$283K Sell
5,645
-6,492
-53% -$317K 0.05% 351
2022
Q3
$529K Buy
12,137
+5,626
+86% +$273K 0.09% 226
2022
Q2
$314K Buy
+6,511
New +$316K 0.06% 327

Other funds holding JIRE

Continuum Advisory's JIRE Position: Q2 2025 in Review

Continuum Advisory sold out of JPMorgan International Research Enhanced Equity ETF (JIRE) in Q2 2025, closing a stake of 135 shares — an estimated $8.6K sold.

Continuum Advisory first reported a position in JIRE in Q2 2022 and held it in 7 quarters. The position peaked at $529K in Q3 2022. 230 funds tracked by Wall St. Rank hold JIRE as of Q2 2025.

  • Continuum Advisory reported no remaining JPMorgan International Research Enhanced Equity ETF position as of Q2 2025 after selling out during the quarter.
  • Continuum Advisory sold 135 JPMorgan International Research Enhanced Equity ETF shares in Q2 2025, an estimated $8.6K.
  • Continuum Advisory first reported a position in JPMorgan International Research Enhanced Equity ETF in Q2 2022 and held it in 7 quarters.
  • Continuum Advisory's JPMorgan International Research Enhanced Equity ETF position peaked at $529K in Q3 2022.
  • 230 funds tracked by Wall St. Rank held JPMorgan International Research Enhanced Equity ETF as of Q2 2025.

Based on Continuum Advisory's 13F filing for Q2 2025, filed 13 Aug 2025.